Loading...
OTC Markets
Totals
Securities
12,225
Dollar Vol
$2.4B
Share Vol
5B
Trades
376,145

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

BGMD
BG Medicine, Inc.

Common Stock
BG Medicine, Inc. Company Logo

303 Wyman Street

Suite 300

Waltham, MA 02451

www.bg-medicine.com

(781) 890-1199

Business Description
BG Medicine, Inc. is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.
Financial Reporting
Reporting Status
Dark: Alternative Reporting Standard
Audited Financials
Not Available
Latest Report
CIK
0001407038
Fiscal Year End
12/31
Company Officers & Contacts
Paul Sohmer
President

Stephen Hall
CFO, EVP

Aram Adourian
Chief Scientific Officer

Board of Directors
Noubar Afeyan

James F. O'Connor

James F. O’Connor, age 74, has over forty years of substantive business experience covering all aspects of finance, operations, strategy and corporate development. Since 1998, Mr. O’Connor has been the principal Managing Director of The Chartwell Company, a merchant and investment banking firm. Mr. O’Connor is a certified public accountant. Some of Mr. O’Connor’s previous directorships include: SPS Technologies (1994-2003), which was sold to Precision Cast Products in 2003; Color Kinetics (2002-2007), which was sold to Phillips Lighting Products in 2007; PC Cox Holding Ltd. (1996-2008); and Caritas Christi Health Care System (2008-2011), which was sold to Cerberus Capital in 2011. Mr. O’Connor received a B.S. from Boston College and was a Rotary International Foundation Fellow at the Swiss School of Economics. Our Board concluded that Mr. O’Connor should serve as a director and our Audit Committee Chairman because Mr. O’Connor has extensive experience in corporate finance, accounting, operations, strategy, mergers & acquisitions, as well as experience working on the boards of directors of public, private and non-for-profit companies.

Stelios Papadopoulos

Paul Sohmer

Harry Wilcox

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Deloitte & Touche LLP

200 Berkley St.

Boston, MA 02116

Securities Counsel
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

One Financial Center

Boston, MA 02111

Profile Data
SIC - Industry Classification
2835 - Diagnostic substances
Incorporation Information
DE, US, 2000
Employees
5 as of 06/30/2015
Shell
No
Products and Services

Not available

Company Facilities

Not available

Expert Market Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.